During the past decade, Little Rock Allergy and Asthma Clinical Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Little Rock Allergy and Asthma Clinical Research Center" are "Asthma" (1 trials) and "Refractory Chronic Cough" (1 trials). Many other conditions were trialed in "Little Rock Allergy and Asthma Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Little Rock Allergy and Asthma Clinical Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BLU-5937" (1 trials), "Budesonide/Formoterol fumarate dihydrate" (1 trials) and "Symbicort" (1 trials). Other intervention names were less common.

The vast majority of trials in "Little Rock Allergy and Asthma Clinical Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Little Rock Allergy and Asthma Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Little Rock Allergy and Asthma Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Little Rock Allergy and Asthma Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".